Answers are grounded in this paper and cite their sources.
Metabolic properties of 6 progestational steroids are compared with progesterone. 1 was shown to be catabolic 2 anabolic and 1 probably salt-retaining; none have been natriuretic. 17-alpha-hydroxyprogesterone is weak in rabbits and man but strong in mice and may be important in renal physiology. When injected it is converted in part to pregnanetriol which is excreted in the urine; patients with adrenogenital syndrome also excrete excessive quantites of pregnanetriol. Urinary sodium and chloride were not enhanced. The esterification of the drug at position 17 has been shown to enhance and prolong the progestational activity. The caproate modification in a 1500 mg dose of 4 successive days induced a mild but distinct catabolic process that lasted as long as the reported progestational effect. 17-alpha-acetoxy-progesterone given orally 60 mg a day for 6 days followed by 120 mg daily for 4 days showed no metabolic effects. Ethynyltestosterone given orally at 200 mg a day for 4 days and then 300 mg a day for 6 days gave a slight anabolic response. It did not enhance protein catabolism. 19-norethynyltestosterone is a very active progestational steroid. Given orally at 40 mg daily it was strongly anabolic. No effect on urinary sodium excretion was found but urinary nitrogen and inorganic phosphorus were reduced. 17-alpha-ethyl-19-nortestosterone was about as potent an anbolic agent as testosterone propionate. 25 mg a day im resulted in an anabolic response of 2 gm a day of nitrogen. This response terminated quickly when the drug was discontinued and was followed by loss of the retained nitrogen. Urinary chloride was not affected. The catabolic influence seems associated only with progestational steroids bearing a beta-oriented side chain at C12 which is the position in naturally-occurring corticoids as well as in progesterone. A ketone group at C20 also appears to be necessary. Progestational compounds with a C17 side chain in the alpha-position tend to be anabolic and salt-retaining. The salt-dissipating action of progesterone probably requires a configuration about C17 similar to that of desoxycorticosterone and aldosterone. Apparently 17-hydroxylation is a sufficient alteration to prevent this effect. Discussion by others follows the paper.
No takes yet. Share an insight, caveat, or question.
Landau et al. (1958) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: